DexCom
DXCM
#788
Rank
NZ$55.13 B
Marketcap
NZ$146.10
Share price
2.95%
Change (1 day)
23.08%
Change (1 year)

EPS for DexCom (DXCM)

EPS in 2026 (TTM): NZ$4.50

According to DexCom's latest financial reports the company's current EPS (TTM) is NZ$4.60. In 2025 the company made an earnings per share (EPS) of NZ$3.82 an increase over its 2024 EPS that were of NZ$2.61.

EPS history for DexCom from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.5017.88%
2025NZ$3.8246.26%
2024NZ$2.614.26%
2023NZ$2.5060.23%
2022NZ$1.5666.82%
2021NZ$0.94
2019NZ$0.48-175.69%
2018NZ-$0.64144.07%
2017NZ-$0.26-24.36%
2016NZ-$0.356.85%
2015NZ-$0.32143.33%
2014NZ-$0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.51 237.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54 20.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.24 57.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
NZ$6.39 39.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$3.09-32.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$1.65-135.91%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
NZ-$27.36-694.98%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
NZ$13.97 203.86%๐Ÿ‡บ๐Ÿ‡ธ USA